期刊文献+

选择性COX-2抑制剂Celecoxib诱导胶质瘤细胞凋亡作用机制初探 被引量:1

Primary Mechanism of Selective COX-2 Inhibitor Celecoxib Induce C6 Glioma Cells Apoptosis in vitro
下载PDF
导出
摘要 背景与目的:选择性COX-2抑制剂具有诱导多种肿瘤细胞凋亡的作用,但在胶质瘤方面研究还不多见,本研究目的是探讨选择性COX-2抑制剂塞来昔布(Celecoxib)诱导胶质瘤C6细胞凋亡,及其在诱导胶质瘤细胞凋亡中的作用机制。方法:应用PGE2检测、吖啶橙染色、流式细胞仪(FCM)检测不同浓度的Celecoxib对胶质瘤C6细胞作用,通过放免法检测不同浓度Celecoxib作用于胶质瘤C6细胞后PGE2的含量,通过吖啶橙染色从形态上观察治疗组细胞的形态学变化,流式细胞仪检测各组细胞发生凋亡的情况。结果:随Celecoxib浓度增加而PGE2合成减少(P>0.05),吖啶橙染色荧光染色对照组细胞核DNA为均匀黄色或黄绿色的荧光,治疗组(Celecoxib50μmol/L)凋亡细胞的细胞核或细胞质内可见致密浓染的黄绿色荧光或黄绿色碎片,Celecoxib浓度为12.5μmol/L和50μmol/L时,FCM法检测凋亡分别为5.83%和15.32%,Celecoxib对C6胶质瘤细胞增殖抑制作用具有浓度依赖性,细胞凋亡随浓度增加而增多。结论:Celecoxib具有诱导胶质瘤C6细胞凋亡的作用并呈剂量依赖性,随PGE2合成下降细胞凋亡增多,PGE2途径是Celecoxib诱导胶质瘤细胞凋亡机制之一,对胶质瘤的治疗有重要意义。 BACKGROUND & OBJECTIVE: To investigate celecoxib's function of inducing C6 glioma cells apoptosis in vitro. METHODS: Cell apoptosis was evaluated by PGE2, acridine orange (AO) stain and flow cytometry(FCM) with different concentration of celecoxib. RESULTS: Apoptosis of C6 glioma cells in treatment group can be seen with AO stain; FCM detected 15.32% and 5.83% apoptosis rate, at different celecoxib concentration of 50μmol/L and 12.5μmol/L, respectively. There was a dose-dependent apoptosis of cell by celecoxib. PGE2 decreased in high dose celecoxib (P〈 0.05). Celeeoxib could increase apoptosis in vitro. CONCLUSION: Celecoxib could induce apoptosis of C6 glioma cells, and PGE2 played an important rule in this course.
出处 《中国神经肿瘤杂志》 2005年第4期273-275,共3页 Chinese Journal of Neuro-Oncology
关键词 CELECOXIB PGE2 胶质瘤 选择性COX-2抑制剂 细胞凋亡 Celeeoxib PGE2 Glioma Apoptosis
  • 相关文献

参考文献4

二级参考文献24

  • 1Dannenberg AJ,Ahorki NK,Boyle JO, et al. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer[ J ]. Lancet Oncol,2001,2(9) :.544-551.
  • 2Howe LR, Dannenberg AJ. A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer [ J ]. Semin Oncol, 2002, 29 (3Suppl-11):111-119.
  • 3Soslow RA, Dannenberg AJ, Rush D, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors [ J ]. Cancer, 2000, 89 ( 12 ) :2637-2645.
  • 4Cao Y, Prescott SM. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer[J]. J Cell Physiol,2002,190(3) : 279-286.
  • 5Tsujii M,Kawano S,Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells[J]. Cell, 1998,93(5): 705-716.
  • 6Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors [ J ]. Cancer Res, 2000, 60 (5) :1306-1311.
  • 7Bailey T, Biddlestone L, Shepherd N, et al. Altered cahem and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence:with disease progression and dedifferentiation[J ]. Am J Pathol, 1998,152(1): 135-144.
  • 8Murata H,Kawano S,Tsuji S, et al. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma[J].Am J Gastroenterol, 1999,94(2) : 451-455.
  • 9Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cydooxygenase-2 expression in breast cancer [ J ]. Cancer Res, 2002, 62.(3): 632-635.
  • 10Denkert C,Kobel M,Pest S, et al. Expression of cydooxygenase 2 is an independent prognostic factor in human ovarian carcinoma [ J ]. Am J Pathol,2002,160(3) :893-903.

共引文献14

同被引文献10

  • 1Smith WL, Marnnett LJ. Prostaglandin-endoperoxide synthas structure and catalysis. Biochim Biophys Acta, 1991, 1083: 1-17.
  • 2Williams CS, DuBois RN. Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol, 1996, 270: 393-400.
  • 3Nakanishi Y. lnhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines. J Europ Can, 2001, 37 : 1570-1578.
  • 4Amin R, Kamitani H, Sultana H, et al. Aspirin and indomethacin exhibit antiproliferative effects and induce apoptosis in T98G human glioblastoma cells. Neurol Res, 2003, 25 : 370-376.
  • 5Svard C, Lijia I, Halbook O, et al. Cyclooxygenase-1 and Cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induce colonic tumours in rats. Gut, 1996,38:79-84.
  • 6Prayson RA, Castilla EA, Vogelbaum MA, et al. Cyclooxygenase-2 (COX-2) expression by immunohistochemistry in glioblastoma multiforme. Ann Diagn Pathol, 2002, 6 : 148.
  • 7Hayashi N. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. Hepatology, 2001, 34: 638-650.
  • 8Mcginty A. COX-2 expression inhibits trophic withdrawal apoprosis in nerve growth factor differentiated PC12 cells. J Biol Chem, 2000,275 : 12095-12101.
  • 9Reardon DA, Quinn JA, Vredenburgh J, et al. Phase Ⅱ trial of irinotecan plus celecoxib in adults with recurrent malignant glioma. Cancer, 2005, 10: 329-338.
  • 10王中华,徐兵河.环氧化酶-2与肿瘤关系的研究进展[J].国外医学(肿瘤学分册),2003,30(4):252-255. 被引量:8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部